Prevalence of Fabry's Disease in a Population of Patients With Chronic Pain

• Register: ClinicalTrials.gov
• Last refreshed on: 21 August 2023
• Main ID: NCT02450604
• Date of registration: 18/05/2015
• Prospective Registration: No
• Primary sponsor: University Hospital, Bordeaux
• Public title: Prevalence of Fabry's Disease in a Population of Patients With Chronic Pain DOUFABIS
• Scientific title: Prevalence of Fabry's Disease in a Population of Patients With Chronic Pain
• Date of first enrolment: March 5, 2015
• Target sample size: 776
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/ct2/show/NCT02450604
• Study type: Interventional
• Study design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
• Phase: N/A

Countries of recruitment

France

Contacts

• Name: Cyril GOIZET
• Affiliation: University Hospital, Bordeaux

Key inclusion & exclusion criteria

Inclusion Criteria:

- patients of both sex,

- aged from 6 to 80,

- with chronic pains of unknown aetiology including: acroparesthesias, and/or pain
crises evolving more than 3 months, continued neuropathic evolving more than 3 months,
and/or multiple pains evolving more than 3 months and/or recurrent abdominal crises of
pain who come for a clinical visit in the pain Centres of France.

Exclusion Criteria:

- chronic pain of known cause



Age minimum: 6 Years
Age maximum: 80 Years
Gender: All

Health Condition(s) or Problem(s) studied

Fabry's Disease

Chronic Pain

Intervention(s)

Genetic: Diagnosis of Fabry disease

Primary Outcome(s)

Diagnosis of Fabry disease in one patient suffering from chronic pains [Time Frame: J1 to 2 months after inclusion]

Secondary ID(s)

CHUBX 2014/23

Source(s) of Monetary Support

Please refer to primary and secondary sponsors